march 20 medicines catalog · global drug facility medicines catalog january 2020 as a unit of the...

Ensuring an uninterrupted supply of quality-assured, affordable tuberculosis (TB) medicines and diagnostics to the world. stoptb.org/gdf

GLOBAL DRUG FACILITY (GDF)

MARCH 2020 MEDICINES CATALOG

http://stoptb.org/gdf

Stop TB Partnership | Global Drug FacilityGlobal Health Campus – Chemin du Pommier 401218 Le Grand-Saconnex | Geneva, SwitzerlandEmail: [email protected]

Last verion's date: 30 March 2020Stop TB Partnership/Global Drug Facility licensed this product under an Attribution-NonCommercial-NoDerivatives 4.0 International License. (CC BY-NC-ND 4.0) https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode

mailto:gdf%40stoptb.org?subject=

https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode

GLOBAL DRUG FACILITYMEDICINES CATALOG JANUARY 2020As a unit of the Stop TB Partnership, GDF provides a range of quality-assured medicines and medical supplies to treat all forms of TB in adults, adolescents and children. This catalog is categorized by products used to treat adults and adolescents as well as children. Each section is subdivided into single medicines and fixed-dose combinations, in alphabetical order by the description. Each product is marked for its intended use, as recommended by WHO, i.e. to treat drug-sensitive TB, drug-resistant TB and/or latent TB infections.

To place an order for any medicine or medical supply, please follow the step-by-step guide available on the GDF website. All prices in this catalogue are listed as ex-works (EXW) prices.

stoptb.org/gdf

http://stoptb.org/gdf

TABLE OF CONTENTSADULT & ADOLESCENT FORMULATIONS

SINGLE MEDICINES

FIXED-DOSE COMBINATIONS

03

06

CHILD-FRIENDLY FORMULATIONS

SINGLE MEDICINES


07

08

MEDICAL SUPPLIES 09

MEDICINES CATALOG 2

ADULT & ADOLESCENT FORMULATIONSThese formulations are indicated for the treatment of all kinds of TB in adults and adolescents.

SINGLE MEDICINES

* Price ranges shown are the lowest and highest available. Actual prices within the indicated rangewill be based on order volume, requested delivery time and country regulatory requirements.For budgetary purposes, countries are encouraged to use the highest price available.** To be used with imipenem/cilastatin or meropenem only

STOP TB PARTNERSHIP GLOBAL DRUG FACILITY 3

AD

ULT

& A

DO

LES

CE

NT

FOR

MU

LA

TIO

NS

PRODUCT CODE

DESCRIPTION (MEDICINE, STRENGTH, FORMULA-TION, PACKAGING)

NUMBER OF UNITS PER PACK

PRICE OR PRICE RANGE

(USD)

Am-500-(A)-10 Amikacin, 500 mg/2 ml, Solution for injection, Ampoule(s)

10 6.21-6.834

Amx/Clv-500/125-(B)-100

Amoxicillin/Clavulanic acid, 500 mg/125 mg, Film coated tablet(s), Blister(s)

100 12.394 **

Amx/Clv-875/125-(B)-100

Amoxicillin/Clavulanic acid, 875 mg/125 mg, Film coated tablet(s), Blister(s)

100 11.804 **

Bdq-100-(L)-188 Bedaquiline, 100 mg, Uncoated tablet(s), HDPE container(s)

188 400.004

Cm-0.5-(V)-1 Capreomycin 0.5 g, Powder, for injection, Vial(s)

1 Please contact GDF

Cm-1-(V)-10 Capreomycin, 1 g, Powder,for injection, Vial(s)


Cfz-100-(L)-100 Clofazimine, 100 mg, Capsule(s), HDPE jar(s)

100 50.00-90.004

Cfz-50-(L)-100 Clofazimine, 50 mg, Capsule(s), HDPE jar(s)

100 35.784

Cs-250-(B)-100 Cycloserine, 250 mg, Capsule(s), Blister(s)

100 24.00-26.304

Dlm-50-(B)-672 Delamanid, 50 mg, Film coated tablet(s), Blister(s)

672 1700.004

* DRUG-

SENSITIVE TB

DRUG-

RESISTANT TB

LATENT

TB INFE

CTION

SINGLE MEDICINES

STOP TB PARTNERSHIP GLOBAL DRUG FACILITY4

AD

ULT

& A

DO

LES

CE

NT

FOR

MU

LA

TIO

NS

PRODUCT CODE




(USD)

E-400-(B)-672 Ethambutol, 400 mg, Film coated tablet(s), Blister(s)

672 20.20-25.004 4

Eto-250-(B)-100 Ethionamide, 250 mg, Film coated tablet(s), Blister(s)

100 8.92-10.634

Imp/Cls-500/500-(V)-10

Imipenem/Cilastatin, 500 mg/500 mg, Powder, for injection, Vial(s)

10 30.504

H-300-(B)-672 Isoniazid, 300 mg, Uncoated tablet(s), Blister(s)

672 11.92-13.524 4 4

Km-0.5-(V)-1 Kanamycin, 0.5 g, Powder, for injection, Vial(s)


Km-1-(V)-50 Kanamycin, 1 g, Powder, for injection, Vial(s)


Km-1-(A)-10 Kanamycin, 1 g/4 ml, Solution for injection, Ampoule(s)


Lfx-250-(B)-100 Levofloxacin, 250 mg, Film coated tablet(s), Blister(s)

100 2.65-3.024


100 3.96-4.664


100 9.904

Lzd-600-(B)-100

Linezolid, 600 mg, Film coated tablet(s), Blister(s)

100 44.20-75.004

Mrp-1-(V)-10 Meropenem, 1 g, Powder, for injection, Vial(s)

10 34.254

Mfx-400-(B)-100

Moxifloxacin, 400 mg, Film coated tablet(s), Blister(s)

100 16.90-25.004

Pa-200-(L)-26 Pretomanid, 200 mg, Tablet(s), Bottle

26 52.004

PAS-(H)-4-(S)-30

PAS Acid, 4 g, Granule(s), Sachet

30 40.004

PAS-(Na)-4-(S)-25

PAS Sodium Salt, 4 g, Granule(s), Sachet

25 33.004

DRUG-

SENSITIVE TB

DRUG-

RESISTANT TB

LATENT

TB INFE

CTION

SINGLE MEDICINES


AD

ULT

& A

DO

LES

CE

NT

FOR

MU

LA

TIO

NS

PRODUCT CODE




(USD)

Pto-250-(B)-100 Prothionamide, 250 mg, Film coated tablet(s), Blister(s)

100 8.74-12.004

Z-400-(B)-672 Pyrazinamide, 400 mg, Uncoated tablet(s), Blister(s)

672 14.00-14.184 4

Z-500-(B)-672 Pyrazinamide, 500 mg, Uncoated tablet(s), Blister(s)

672 12.91-14.004 4

Pyr(B6)-100-(L)-250

Pyridoxine, 100 mg, Uncoated tablet(s), HDPE jar(s)

250 11.554 4 4

Pyr(B6)-50-(B)-50

Pyridoxine, 50 mg, Film coated tablet(s), Blister(s)

50 0.704 4 4

Rbt-150-(L) -100 Rifabutin, 150 mg, Capsule(s), HDPE jar(s)

100 94.534

R-150-(B)-100 Rifampicin, 150 mg, Film coated tablet(s), Blister(s)

100 6.334 4

R-300-(B)-100 Rifampicin, 300 mg, Film coated tablet(s), Blister(s)

100 10.004 4

Rpt-150-(B)-24 Rifapentine, 150 mg, Film coated tablet(s), Blister(s)

24 15.004

S-1-(V)-10 Streptomycin, 1 g, Powder, for injection, Vial(s)

10 5.414

Trd- 250- (B)-100

Terizidone, 250 mg, Capsule(s), Blister(s)

100 175.004

DRUG-

SENSITIVE TB

DRUG-

RESISTANT TB

LATENT

TB INFE

CTION

*

* Discount price of 5.25 USD per pack may apply to eligible countries for limited time.Please contact your GDF Country Supply Officer or write to [email protected] for further information.

mailto:[email protected]



AD

ULT

& A

DO

LES

CE

NT

FOR

MU

LA

TIO

NS

PRODUCT CODE

DESCRIPTION MEDICINE, STRENGTH, FORMULA-TION, PACKAGING)



(USD)

PK-Cat I & III-A Cat I & III Kit A, Film coated tablet(s), Blister(s)

1 26.62-26.894

HPST-Q-TIB-(L)-30

Isoniazid/Pyridoxine hydrochl/Sulfamethoxazole/Trimethoprim,300 mg/ 25 mg/800 mg/160 mg, Uncoated tablet(s), HDPE container(s)

30 1.99

4

2-FDC/RH-150/75-(B)-336

Rifampicin/Isoniazid, 150 mg/75 mg, Film coated tablet(s), Blister(s)

336 13.634

2-FDC/RH-150/75-(B)-672

Rifampicin/Isoniazid, 150 mg/75 mg, Film coated tablet(s), Blister(s)

672 20.69-25.934

3-FDC/RHE-150/75/275-(B)-672

Rifampicin/Isoniazid/Ethambutol, 150 mg/75 mg/275 mg, Film coated tablet(s), Blister(s)

672 37.69-42.46

4

4-FDC/RHZE-150/75/400/275-(B)-336

Rifampicin/Isoniazid/Pyrazinamide/Ethambutol, 150 mg/75 mg/400 mg/ 275 mg, Film coated tablet(s), Blister(s)

336 27.29

4

4-FDC/RHZE-150/75/400/275-(B)-672

Rifampicin/Isoniazid/Pyrazinamide/Ethambutol, 150 mg/75 mg/400 mg/ 275 mg, Film coated tablet(s), Blister(s)

672 47.87-52.75

4

DRUG-

SENSITIVE TB

DRUG-

RESISTANT TB

LATENT

TB INFE

CTION

3-HP-300/ 300-(B)-36

Rifapentine/Isoniazid 300mg/300mg, Film coated tablet(s), Blister(s)

36 15.004

CHILD-FRIENDLY FORMULATIONSThese formulations make it easier for care-givers to give the correct doses and are simpler to administer to children.

SINGLE MEDICINES

* To be used with imipenem/cilastatin or meropenem only.


CH

ILD-FR

IEN

DLY

FOR

MU

LA

TIO

NS

PRODUCT CODE




(USD)

Cfz-50-(B)-100 Clofazimine, 50 mg, Tablet(s), Blister(s)

100 49.124

Cs-125-(B)-100 Cycloserine, 125 mg, Capsule(s), Blister(s)

100 454

E-100- (B-DT)-100

Ethambutol, 100 mg, Dispersible tablet(s), Blister(s)

100 22.504 4

E-100-(B)-100 Ethambutol, 100 mg, Film coated tablet(s), Blister(s)

100 3.75-4.304 4

Eto-125-(B-DT)-100

Ethionamide, 125 mg, Dispersible tablet(s), Blister(s)

100 13.004

H-100- (B-DT)-100

Isoniazid, 100 mg, Dispersible tablet(s), Blister(s)

100 9.91-10.004 4 4

H-100-(B)-100 Isoniazid, 100 mg, Uncoated tablet(s), Blister(s)

100 1.03-1.414 4 4

Lfx-100- (B-DT)-100

Levofloxacin, 100 mg, Dispersible tablet(s), Blister(s)

100 12.914

Mfx-100- (B-DT)-100

Moxifloxacin, 100 mg, Dispersible tablet(s), Blister(s)

100 19.904

Z-150-(B-DT)-100 Pyrazinamide, 150 mg, Dispersible tablet(s),

100 9.404 4

DRUG-

SENSITIVE TB

DRUG-

RESISTANT TB

LATENT

TB INFE

CTION



CH

ILD-FR

IEN

DLY

FOR

MU

LA

TIO

NS

PRODUCT CODE




(USD)

2-FDC/RH-75/50-(B)-84

Rifampicin/Isoniazid, 75 mg/50 mg, Dispersible tablet(s), Strip(s)

84 2.87-3.004 4

3-FDC/RHZ-75/50/150-(B)-84

Rifampicin/Isoniazid/ Pyrazinamide, 75 mg/50mg/150 mg, Dispersible tablet(s), Blister(s)

84 3.60

4

DRUG-

SENSITIVE TB

DRUG-

RESISTANT TB

LATENT

TB INFE

CTION

MEDICAL SUPPLIESGDF facilitates access to medical supplies used in treating TB.

PRODUCT CODE

DESCRIPTION(PRODUCT, PACKAGING)



(USD)

S&N - 5 ml/21/22/23 G (RUP/SIP) and Safety Box, 5lt

Auto-disable, reuse-prevention syringes with sharp infury prevention, 5ml, 21/22/23 G, individual sterilized peel-off pack, and Safety Box, 5lt.

100 5.00

4

S&N - 5 ml/21/22/23 G and Safety Box, 5lt

Auto-disable syringes with sharp infury prevention, 5ml, 21/22/23 G, individual sterilized peel-off pack, and Safety Box, 5lt.

100 5.00

4

WFI-5-(V)-50 Water for injections, Solution for injection, Vial(s)

50 4.454


ME

DIC

AL S

UP

PLIE

SDRUG-

SENSITIVE TB

DRUG-

RESISTANT TB

LATENT

TB INFE

CTION

Stop TB Partnership | Global Drug FacilityGlobal Health Campus – Chemin du Pommier 401218 Le Grand-Saconnex | Geneva, SwitzerlandEmail: [email protected]

mailto:gdf%40stoptb.org?subject=

march 20 medicines catalog · global drug facility medicines catalog january 2020 as a unit of the...

Documents